$115.72
6.315.77%
Last update: Nov 4, 1:14 PM
Abbott Laboratories (ABT) Stock Price, Quote, News & History
ABTNYSE
Abbott reports positive trial results for its Amulet 360 LAA occluder and SonicForce coronary IVL system at a conference.
You can purchase shares of Abbott Laboratories (NYSE:ABT) through any online brokerage.
Other companies in Abbott Laboratories’s space includes: Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK), Boston Scientific Corp (NYSE:BSX) and Becton Dickinson & Co (NYSE:BDX).
Abbott Laboratories has a consensus price target of $127.00.
The stock price for Abbott Laboratories (NYSE: ABT) is $115.715 last updated November 4, 2026 at 1:14 PM EST.
There are no upcoming dividends for Abbott Laboratories.
Abbott Laboratories does not have any upcoming earnings scheduled.
There is no upcoming split for Abbott Laboratories.
Abbott Laboratories is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators,...
